Waters Corporation (NYSE: WAT) announced today that both its new full spectrum molecular imaging system and its ACQUITY® UltraPerformance LC® (UPLC®) Technology received awards at the 2015 Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy.
Waters plans to begin shipments of its full spectrum molecular imaging system in the third quarter of 2015.ACQUITY UPLC Technology First introduced in 2004, the ACQUITY UPLC System is acclaimed for its enhanced speed, resolution and sensitivity, while also improving the quality of results. By outperforming traditional or optimized HPLC, the ACQUITY UPLC System allows chromatographers to work at higher efficiencies with a much wider range of linear velocities, flow rates, and backpressures. "We are tremendously proud that the ACQUITY UPLC System was recognized with the Reviewers' Choice Award. This award is particularly significant because it is decided on by the scientific community, whose success is Waters' ultimate mission," said Ian King Ph.D., Vice President, Separations Technology, Waters Division. "Whether you work in methods development or quality assurance, drug discovery or food safety testing, UPLC Technology is proven to provide measurable scientific and business benefits." UPLC Technology, which has been adopted successfully in laboratories around the world for the most demanding separations, is highly robust, dependable, and reproducible. What differentiates the holistic design of ACQUITY UPLC systems is Waters' patented 1.7 micron hybrid particle chemistry. The ACQUITY UPLC System was a Pittcon Editor's Gold Award winner in 2004. Please visit Waters.com for more details of the full portfolio of ACQUITY UPLC systems. About Waters Corporation ( www.waters.com ) For over 50 years, Waters Corporation (NYSE: WAT) has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, water quality, consumer products and high value-added chemicals worldwide. Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success. With revenue of $1.99 billion in 2014, Waters is driving scientific discovery and operational excellence for customers worldwide.
Waters, ACQUITY, UltraPerformance LC, UPLC, and SYNAPT are trademarks or registered trademarks of Waters Corporation.